Aethlon Medical shares are trading higher after the company announced that it has entered into a definitive merger agreement for an all-stock transaction with North Immunology.

Benzinga Newsdesk www.benzinga.com Positive 95.1%

Neg 0% Neu 0% Pos 95.1%

Comments

No comments yet. Be the first!